5,504
Views
18
CrossRef citations to date
0
Altmetric
Original Investigations

Lifetime and current depression in the German National Cohort (NAKO)

, , , , , , , , , , , , , , , & show all, , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 865-880 | Received 03 Jun 2021, Accepted 01 Dec 2021, Published online: 17 Feb 2022

References

  • American Psychiatric Association A. 1994. Diagnostic and statistical manual of mental disorders (DSM-IV).
  • Angst J, Gamma A, Endrass J. 2003. Risk factors for the bipolar and depression spectra. Acta Psychiatr Scand Suppl. 108(418):15–19.
  • Baumeister SE, Schomerus G, Schmidt C-O, Möckel F, van den Berg N, Hoffmann W, Völzke H, Grabe HJ. 2015. Change in depressive symptoms and mental health-related quality of life in northeast Germany between 1997-2001 and 2008-2012. Int J Public Health. 60(1):33–39.
  • Berger K, Rietschel M, Rujescu D. 2022. Editorial – The value of ‘mega cohorts’ for psychiatric research. World J Biol Psychiatry. [ahead of print]. doi:10.1080/15622975.2021.2011405
  • Bretschneider J, Janitza S, Jacobi F, Thom J, Hapke U, Kurth T, Maske UE. 2018. Time trends in depression prevalence and health-related correlates: results from population-based surveys in Germany 1997-1999 vs. 2009-2012. BMC Psychiatry. 18(1):394.
  • Bretschneider J, Kuhnert R, Hapke U. 2017. Depressive symptoms among adults in Germany. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung.
  • Buch AM, Liston C. 2021. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 46(1):156–175.
  • Busch M, Maske U, Ryl L, Schlack R, Hapke U. 2013. Prevalence of depressive symptoms and diagnosed depression among adults in Germany.
  • Cai N, Choi KW, Fried EI. 2020. Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies. Hum Mol Genet. 29(R1):R10–R18.
  • Cai N, Revez JA, Adams MJ, Andlauer TFM, Breen G, Byrne EM, Clarke TK, Forstner AJ, Grabe HJ, Hamilton SP, et al. 2020. Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 52(4):437–447.
  • Chaplin AB, Jones PB, Khandaker GM. 2021. Sexual and physical abuse and depressive symptoms in the UK Biobank. BMC Psychiatry. 21(1):1–10.
  • Davis KAS, Coleman JRI, Adams M, Allen N, Breen G, Cullen B, Dickens C, Fox E, Graham N, Holliday J, et al. 2020. Mental health in UK Biobank – development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis. BJPsych Open. 6(2):e18.
  • Dragano N, Reuter M, Greiser KH, Becher H, Zeeb H, Mikolajczyk R, Kluttig A, Leitzmann M, Fischer B, Jockel KH, et al. 2020. [Socio-demographic and employment-related factors in the German National Cohort (GNC; NAKO Gesundheitsstudie)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 63(3):267–278.
  • Erhardt A, Gelbrich G, Klinger-König J, Streit F, Kleineidam L, Riedel-Heller S, NAKO Investigators, Schmiedek F, Wagner M, Grabe H, et al. 2022. Generalized anxiety and panic symptoms in the German National Cohort (NAKO). World J Biol Psychiatry. [ahead of print]. doi: 10.1080/15622975.2021.2011409
  • Erhart M, von Stillfried D. 2012. Analyse regionaler Unterschiede in der Prävalenz und Versorgung depressiver Störungen auf Basis vertragsärztlicher Abrechnungsdaten–Teil 1 Prävalenz. Berlin: Zentralinstitut für die kassenärztliche Versorgung in Deutschland.
  • File SE. 1996. Recent developments in anxiety, stress, and depression. Pharmacol Biochem Behav. 54(1):3–12.
  • First MB, Gibbon M. 2004. The structured clinical interview for DSM-IV axis I disorders (SCID-I) and the structured clinical interview for DSM-IV axis II disorders (SCID-II). Comprehen Handbook Psychol Assessment. 2:134–143.
  • Fried EI, Nesse RM. 2015. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 172:96–102.
  • German National Cohort Consortium. 2014. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 29:371–382.
  • Glanville KP, Coleman JRI, Howard DM, Pain O, Hanscombe KB, Jermy B, Arathimos R, Hübel C, Breen G, O’Reilly PF, et al. 2020. Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank. medRxiv.2020.2009.2018.20196451.
  • Grafe K, Zipfel S, Herzog W, Lowe B. 2004. Screening for psychiatric disorders with the Patient Health Questionnaire (PHQ). Results from the German validation study. Diagnostica. 50(4):171–181.
  • Hagenaars SP, Coleman JRI, Choi SW, Gaspar H, Adams MJ, Howard DM, Hodgson K, Traylor M, Air TM, Andlauer TFM, et al. 2020. Genetic comorbidity between major depression and cardio‐metabolic traits, stratified by age at onset of major depression. Am J Med Genet B Neuropsychiatr Genet. 183(6):309–330.
  • He C, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Krishnan A, Wu Y, Sun Y, et al. 2020. The accuracy of the patient health questionnaire-9 algorithm for screening to detect major depression: an individual participant data meta-analysis. Psychother Psychosom. 89(1):25–37.
  • Jacobi F, Hofler M, Meister W, Wittchen HU. 2002. [Prevalence, detection and prescribing behavior in depressive syndromes. A German federal family physician study]. Nervenarzt. 73(7):651–658.
  • Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, Lieb R. 2004. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 34(4):597–611.
  • James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al. 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 392(10159):1789–1858.
  • Jermy BS, Glanville KP, Coleman JRI, Lewis CM, Vassos E. 2020. What’s in a diagnosis? A genetic decomposition of major depression. medRxiv.2020.2012.2015.20247015.
  • Jermy BS, Hagenaars SP, Glanville KP, Coleman JRI, Howard DM, Breen G, Vassos E, Lewis CM. 2020. Using major depression polygenic risk scores to explore the depressive symptom continuum. bioRxiv.2020.2002.2025.962704.
  • Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2005. Age at onset and familial risk for major depression in a Swedish national twin sample. Psychol Med. 35(11):1573–1579.
  • Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C. 2020. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry. 25(2):321–338.
  • Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB. 2007. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 20(4):359–364.
  • Kleineidam L, Stark M, Riedel-Heller S, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, et al. 2022. The assessment of cognitive function in the German National Cohort (NAKO) – Associations of demographics and psychiatric symptoms with cognitive test performance. World J Biol Psychiatry. [ahead of print]. doi: 10.1080/15622975.2021.2011408
  • Klinger-König J, Streit F, Erhardt A, Kleineidam L, Schmiedek F, NAKO Investigators, Wagner M, Deckert J, Rietschel M, Berger K, et al. 2022. The Assessment of childhood maltreatment and its associations with affective symptoms in adulthood: results of the german national cohort (NAKO). World J Biol Psychiatry. [ahead of print]. doi: 10.1080/15622975.2021.2011406
  • Krishnan V, Nestler EJ. 2010. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry. 167(11):1305–1320.
  • Kroenke K, Spitzer RL, Williams JB. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16(9):606–613.
  • Kroenke K, Spitzer RL, Williams JB, Lowe B. 2010. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 32(4):345–359.
  • Laursen TM, Musliner KL, Benros ME, Vestergaard M, Munk-Olsen T. 2016. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord. 193:203–207.
  • Lecrubier Y, Weiller E, Herugeta T, Amorim P, Bonora L, Lépine J. 1999. Mini International Neuropsychiatric Interview German Version 5.0. 0. München: Psychiatrischen Universitätsklinik München.
  • Levis B, Benedetti A, Thombs BD. 2019. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 365:l1476.
  • Lorant V, Deliege D, Eaton W, Robert A, Philippot P, Ansseau M. 2003. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 157(2):98–112.
  • Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. 2004. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 78(2):131–140.
  • Löwe B, Spitzer RL, Zipfel S, Herzog W. 2017. Autorisierte deutsche Version des “Prime MD Patient Health Questionnaire (PHQ)”.
  • Maier W, Falkai P. 1999. The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol. 14:S1–S6.
  • Manea L, Gilbody S, McMillan D. 2012. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 184(3):E191–196.
  • Manea L, Gilbody S, McMillan D. 2015. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 37(1):67–75.
  • Martin J, Streit F, Treutlein J, Lang M, Frank J, Forstner AJ, Degenhardt F, Witt SH, Schulze TG, Cichon S, et al. 2017. Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist. Psychiatr Genet. 27(5):187–196.
  • Maske UE, Busch MA, Jacobi F, Beesdo-Baum K, Seiffert I, Wittchen HU, Riedel-Heller S, Hapke U. 2015. Current major depressive syndrome measured with the Patient Health Questionnaire-9 (PHQ-9) and the Composite International Diagnostic Interview (CIDI): results from a cross-sectional population-based study of adults in Germany. BMC Psychiatry. 15(1):77.
  • Maske UE, Buttery AK, Beesdo-Baum K, Riedel-Heller S, Hapke U, Busch MA. 2016. Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany. J Affect Disord. 190:167–177.
  • Milaneschi Y, Lamers F, Peyrot WJ, Baune BT, Breen G, Dehghan A, Forstner AJ, Grabe HJ, Homuth G, Kan C, et al. 2017. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 74(12):1214–1225.
  • Moriarty AS, Gilbody S, McMillan D, Manea L. 2015. Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): a meta-analysis. Gen Hosp Psychiatry. 37(6):567–576.
  • Peters A, Rospleszcz S, Greiser KH, Dallavalle M, Berger K. 2020. The impact of the COVID-19 pandemic on self-reported health. Dtsch Arztebl Int. 117(50):861–867.
  • Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA. 1988. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 45(12):1069–1077.
  • Sander JB, McCarty CA. 2005. Youth depression in the family context: familial risk factors and models of treatment. Clin Child Fam Psychol Rev. 8(3):203–219.
  • Sartorius N, Ustun T, Organization WH 1995. Mental illness in general health care: an international study. Chichester: Wiley.
  • Schipf S, Schöne G, Schmidt B, Günther K, Stübs G, Greiser KH, Bamberg F, Meinke-Franze C, Becher H, Berger K, et al. 2020. [The baseline assessment of the German National Cohort (NAKO Gesundheitsstudie): participation in the examination modules, quality assurance, and the use of secondary data]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 63(3):254–266.
  • Schlax J, Junger C, Beutel ME, Munzel T, Pfeiffer N, Wild P, Blettner M, Kerahrodi JG, Wiltink J, Michal M. 2019. Income and education predict elevated depressive symptoms in the general population: results from the Gutenberg health study. BMC Public Health. 19(1):430.
  • Schmiedek F, Kroehne U, Goldhammer F, Prindle JJ, Lindenberger U, Klinger-König J, Grabe HJ, Riedel-Heller SG, Pabst A, Streit F, et al. 2022. General cognitive ability assessment in the German National Cohort (NAKO) – The block-adaptive number series task. World J Biol Psychiatry. [ahead of print]. doi: 10.1080/15622975.2021.2011407
  • Schneider F, Erhart M, Hewer W, Loeffler LA, Jacobi F. 2019. Mortality and medical comorbidity in the severely mentally ill: a German Registry Study. Dtsch Arztebl Int. 116(23–24):405–411.
  • Sheehan D. 1998. MINI-Mini International neuropsychiatric interview-english version 5.0. 0-DSM-IV. J Clin Psychiatry. 59:34–57.
  • Spitzer RL, Kroenke K, Williams JB, Lowe B. 2006. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 166(10):1092–1097.
  • Steffen A, Nübel J, Jacobi F, Bätzing J, Holstiege J. 2020. Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data. BMC Psychiatry. 20(1):15.
  • Streiner DL, Patten SB, Anthony JC, Cairney J. 2009. Has ‘lifetime prevalence’ reached the end of its life? An examination of the concept. Int J Methods Psychiatr Res. 18(4):221–228.
  • Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. 2015. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12(3):e1001779.
  • Takayanagi Y, Spira AP, Roth KB, Gallo JJ, Eaton WW, Mojtabai R. 2014. Accuracy of reports of lifetime mental and physical disorders: results from the Baltimore Epidemiological Catchment Area study. JAMA Psychiatry. 71(3):273–280.
  • Tegethoff M, Stalujanis E, Belardi A, Meinlschmidt G. 2016. Chronology of onset of mental disorders and physical diseases in mental-physical comorbidity – a national representative survey of adolescents. PLoS One. 11(10):e0165196.
  • Trautmann S, Beesdo-Baum K. 2017. The treatment of depression in primary care: a cross-sectional epidemiological study. Deutsches Ärzteblatt International. 114(43):721.
  • Tyrer P. 2014. A comparison of DSM and ICD classifications of mental disorder. Adv Psychiatr Treat. 20(4):280–285.
  • UNESCO United Nations Educational, Scientific and Cultural Organization. 2003. International Standard Classification of Education, ISCED 1997. Advances in Cross-National Comparison: A European Working Book for Demographic and Socio-Economic Variables.195-220.
  • Wickham H. 2011. ggplot2. WIREs Comp Stat. 3(2):180–185.
  • Wittchen HU, Pittrow D. 2002. Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study. Hum Psychopharmacol. 17(S1):S1–S11.
  • World Health Organization. 1993. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Vol. 2. Geneva; World Health Organization.
  • Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E, Air TM, Andlauer TMF, et al. 2018. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 50(5):668–681.